Benzinga | Aug 6, 2020 04:08PM EDT

Earnings Outlook for Ocular Therapeutix

Ocular Therapeutix (NASDAQ: OCUL) announces its next round of earnings this Friday, August 07. Here is Benzinga's look at Ocular Therapeutix's Q2 earnings report.

Earnings and Revenue

Sell-side analysts are expecting Ocular Therapeutix's loss per share to be near $0.31. In the same quarter last year, Ocular Therapeutix posted EPS of $-0.57. If the company were to post earnings in-line with the consensus estimate when it reports Friday, EPS would be up 45.61%. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019EPS Estimate -0.37 -0.45 -0.47 -0.48EPS Actual -0.41 -0.53 -0.45 -0.57Revenue Estimate 2.84 M 2.54 M 580.00 K 740.00 KRevenue Actual 2.61 M 2.26 M 829.00 K 650.00 K

Stock Performance

Over the last 52-week period, shares are up 93.1%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. Ocular Therapeutix is scheduled to hold the call at 08:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/ze3bnc2d